This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar 2;8(3):122.

doi: 10.1038/nrrheum.2012.17.

Therapy: Silencing inhibitors of bone formation

PMID: 22388697
DOI: 10.1038/nrrheum.2012.17

Comment

Therapy: Silencing inhibitors of bone formation

Katrina Ray. Nat Rev Rheumatol. 2012.

. 2012 Mar 2;8(3):122.

doi: 10.1038/nrrheum.2012.17.

Author

PMID: 22388697
DOI: 10.1038/nrrheum.2012.17

No abstract available

PubMed Disclaimer

Comment on

A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy.
Zhang G, Guo B, Wu H, Tang T, Zhang BT, Zheng L, He Y, Yang Z, Pan X, Chow H, To K, Li Y, Li D, Wang X, Wang Y, Lee K, Hou Z, Dong N, Li G, Leung K, Hung L, He F, Zhang L, Qin L. Zhang G, et al. Nat Med. 2012 Jan 29;18(2):307-14. doi: 10.1038/nm.2617. Nat Med. 2012. PMID: 22286306

References

1. Nat Rev Drug Discov. 2009 Feb;8(2):129-38 - PubMed
1. Nat Med. 2012 Jan 29;18(2):307-14 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.